Sanofi Seeks Certiorari Over Change Of Law Forfeiture, Patent Obviousness Standard

Mealey's (July 28, 2020, 3:08 PM EDT) -- WASHINGTON, D.C. — In a June 26 petition for certiorari in the U.S. Supreme Court, pharmaceutical firm Sanofi-Aventis Deutschland GMBH seeks review of two areas in patent law:  the application or...
To view the full article, register now.